1. Guidance for Industry Clinical Development of Steroidal Contraceptives Used by Women. Health Products and Food Branch. Available at: http://www.hc-sc.gc.ca/hpfb-dgpsa/tpd-dpt/steroidal_contraceptives_e.html. Accessed August 2003.
2. Therapeutic Products Programme policy, Submissions for Topical Non-Steroidal Anti-inflammatory Drugs (Topical NSAID's). Available at: http://www.he-sc.gc.ca/hpfb-dgpsa/tpd-dpt/topnsaid_e.html. Accessed August 2003.
3. Note for guidance on the clinical investigation of medicinal products in the treatment of asthma. EMEA, CPMP. Available at: http://www.emea.eu.int/pdfs/human/ewp/29220len.pdf.Accessed August 2003.
4. Points to consider on clinical investigation of medicinal products for acute stroke. EMEA, CPMP. Available at: http://www.emea.eu.int/pdfs/human/ewp/056098en.pdf. Accessed August 2003.
5. Appendix to the note for guidance on the clinical investigation of medicinal products in the treatment of schizophrenia-methodology of clinical trials concerning the development of depot preparations of approved medicinal products in schizophrenia. EMEA, CPMP. Available at: http://www.emea.eu.int/pdfs/human/ewp/004901en.pdf. Accessed August 2003.